retatrutide study news today New Tirzepatide & dual trial! : r/Zepbound retatrutide type 2 diabetes phase

Two people on the same program may not be on identical plans

LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept PMID: 35114046 Cell Metab

What's Next: Upcoming Readouts in 2026 TRIUMPH-1 (pivotal obesity) on May 21, 2026 (up to -30.3% at 104 weeks), and TRIUMPH-2 and TRIUMPH-3 together on July 23, 2026 (-20.8% and -22.6% at 12 mg)

LDL cholesterol, the so-called bad cholesterol, shows meaningful reductions though not as dramatic as triglycerides

As of mid-2025, retatrutide is not approved for clinical use in the United Kingdom

Surgeons observe phenomena they call Ozempic face or Ozempic buttloose skin or loss of fullness in the face or buttocks after significant weight falls away